SEC Form 4 research
| Issuer | X4 Pharmaceuticals, Inc |
|---|---|
| Tickers | XFOR, ASNS |
| Reporting owners | 84 |
| Officers and directors | 17 |
| Last public filing | 2026-10-19 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-19 | 2026-10-16 | Craig Adam R | P | 4,600 | $2.58 | Not reported |
| 2026-10-05 | 2026-10-01 | KIRSKE DAVID | S | 11,767 | $2.86 | Not reported |
| 2026-08-13 | 2026-08-12 | Volpone John | S | 24,576 | $4.44 | Not reported |
| 2026-08-13 | 2026-08-12 | Craig Adam R | S | 47,436 | $4.44 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.